In animal model, a booster dose with a vaccine containing the mycobacterial HSP65 gene could promote protection against MS and increased level of antibodies to HSP70 in Sardinian patients with MS and MAP DNA was detected in the peripheral blood in MS patients [27]. This evidence concerns the gene HSPD1 and myeloid sarcoma.